Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Sep;26(3):373–377. doi: 10.1128/aac.26.3.373

Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits.

C Carbon, F Dromer, N Brion, A C Cremieux, A Contrepois
PMCID: PMC176173  PMID: 6391371

Abstract

Excretion of ceftazidime (C), a new cephalosporin antibiotic, has been reported to occur unexpectedly through glomerular filtration only, without being significantly affected by probenecid. We investigated renal tubular disposition of C in rabbits by calculating its rates of fractional excretion, net tubular secretion, and absolute excretion. During continuous intravenous infusion of C, 3 mg of furosemide (F), 15 mg of probenecid (P), or 2 mg of indomethacin (I) per kg was injected intravenously as a bolus. Equilibrium dialysis showed that the percentage of C bound to serum proteins (14 +/- 5%) was not altered by F, P, or I. Fractional excretion of C was 94 +/- 22, 65 +/- 21, 182 +/- 36, and 98 +/- 3% for the drug given alone and after injection of F, P, and I, respectively. For 15 min after P injection, we observed net tubular secretion of C (404 +/- 276 micrograms/min). The C absolute excretion rate was significantly reduced by I compared with the absolute excretion rate for the control (405 +/- 104 versus 696 +/- 157 micrograms/min). We conclude that (i) C undergoes bidirectional transport in the nephron, revealed by the effects of F and P, with a nil net C balance; (ii) F and P have opposite unexpected effects on tubular handling of C, possibly due to competition for C secretion processes; (iii) I reduces C excretion solely by decreasing its glomerular-filtered load; and (iv) tubular handling of C differs from that of previously studied cephalosporins.

Full text

PDF
376

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baylis C., Brenner B. M. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ Res. 1978 Dec;43(6):889–898. doi: 10.1161/01.res.43.6.889. [DOI] [PubMed] [Google Scholar]
  2. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carbon C., Contrepois A., Brion N., Lamotte-Barrillon S. Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits. Antimicrob Agents Chemother. 1977 Apr;11(4):594–598. doi: 10.1128/aac.11.4.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carbon C., Contrepois A., Nivoche Y., Grandjean M., Decourt S., Chau N. P. Effects of phenylbutazone on extravascular diffusion, protein binding and urinary excretion of cefazolin in rabbits. J Pharmacol Exp Ther. 1981 Aug;218(2):537–543. [PubMed] [Google Scholar]
  5. Carbon C., Contrepois A., Vigneron A. M., Lamotte-Barrillon S. Effects of furosemide on extravascular diffusion, protein binding and urinary excretion of cephalosporins and aminoglycosides in rabbits. J Pharmacol Exp Ther. 1980 Jun;213(3):600–606. [PubMed] [Google Scholar]
  6. Cunningham R. F., Israili Z. H., Dayton P. G. Clinical pharmacokinetics of probenecid. Clin Pharmacokinet. 1981 Mar-Apr;6(2):135–151. doi: 10.2165/00003088-198106020-00004. [DOI] [PubMed] [Google Scholar]
  7. DAYTON P. G., YU T. F., CHEN W., BERGER L., WEST L. A., GUTMAN A. B. The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material. J Pharmacol Exp Ther. 1963 Jun;140:278–286. [PubMed] [Google Scholar]
  8. DeSante K. A., Israel K. S., Brier G. L., Wolny J. D., Hatcher B. L. Effect of probenecid on the pharmacokinetics of moxalactam. Antimicrob Agents Chemother. 1982 Jan;21(1):58–61. doi: 10.1128/aac.21.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dedrick R. L. Animal scale-up. J Pharmacokinet Biopharm. 1973 Oct;1(5):435–461. doi: 10.1007/BF01059667. [DOI] [PubMed] [Google Scholar]
  10. Helleberg L. Clinical Pharmacokinetics of indomethacin. Clin Pharmacokinet. 1981 Jul-Aug;6(4):245–258. doi: 10.2165/00003088-198106040-00001. [DOI] [PubMed] [Google Scholar]
  11. Jovanovich J. F., Saravolatz L. D., Burch K., Pohlod D. J. Failure of probenecid to alter the pharmacokinetics of ceforanide. Antimicrob Agents Chemother. 1981 Oct;20(4):530–532. doi: 10.1128/aac.20.4.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lüthy R., Blaser J., Bonetti A., Simmen H., Wise R., Siegenthaler W. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother. 1981 Nov;20(5):567–575. doi: 10.1128/aac.20.5.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nivoche Y., Contrepois A., Cremieux A. C., Carbon C. Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide. J Pharmacol Exp Ther. 1982 Jul;222(1):237–240. [PubMed] [Google Scholar]
  14. Shimada J., Yamaji T., Miyahara T., Ueda Y., Kawabata T., Sugeno K., Yoshida T., Nakamura M. Renal disposition of moxalactam in experimental animals as revealed by stop-flow analysis. Antimicrob Agents Chemother. 1983 Jan;23(1):8–14. doi: 10.1128/aac.23.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Welling P. G., Dean S., Selen A., Kendall M. J., Wise R. Probenecid: an unexplained effect on cephalosporin pharmacology. Br J Clin Pharmacol. 1979 Nov;8(5):491–495. doi: 10.1111/j.1365-2125.1979.tb01032.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES